L81.1
Chloasma
Clinical Classification Guidelines
Medical Intelligence & Overview
Chloasma, also known as melasma, is a common skin condition characterized by dark, irregular patches typically appearing on the face. It primarily affects women, especially during pregnancy or while taking hormonal contraceptives, but can also occur in men. Although it is not harmful physically, chloasma can be a source of cosmetic concern for many individuals. Understanding its causes, symptoms, diagnosis, and treatment options can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Hormonal changes during pregnancy, use of oral contraceptives, or hormone replacement therapy Sun exposure, which stimulates melanin production and exacerbates pigmentation Genetic predisposition and family history of melasma Certain skincare products or cosmetics that irritate the skin Thyroid disorders and other underlying health conditions
Key Symptoms: Dark, brown, or grayish patches on the skin Irregularly shaped pigmentation spots, often symmetrical on both sides of the face Commonly appearing on the cheeks, forehead, upper lip, and chin Patches may become more prominent with sun exposure No physical discomfort or pain associated with the patches
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chloasma is primarily clinical, based on visual examination by a healthcare provider. They assess the appearance, location, and texture of the skin patches. In some cases, additional tests such as skin biopsy or Wood's lamp examination may be performed to distinguish it from other pigmentation disorders or skin conditions. The healthcare provider may also review the patient’s medical history and potential contributing factors like hormonal status or sun exposure habits.
Treatment Protocols: Sun protection: Using broad-spectrum sunscreens daily and wearing protective clothing to minimize sun exposure. Topical treatments: Ingredients like hydroquinone, tretinoin, corticosteroids, azelaic acid, or others recommended by a dermatologist to lighten hyperpigmentation. Procedural options: Chemical peels, laser therapy, or intense pulsed light (IPL) treatments can sometimes reduce pigmentation, performed by qualified professionals. Addressing underlying causes: Adjusting hormonal therapies if appropriate and managing any thyroid or hormonal disorders. Lifestyle modifications: Avoiding excessive sun exposure and using gentle skincare products to prevent aggravation of pigmentation.
Clinical Advice & FAQs
Billing Guidance
Is L81.1 a billable ICD-10 code?
Yes, L81.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L81.1?
Clinical documentation must specify the nature of Chloasma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference